Literature DB >> 19648281

Antigen receptor signals rescue B cells from TLR tolerance.

Jayakumar S Poovassery1, Tony J Vanden Bush, Gail A Bishop.   

Abstract

Interactions between innate and adaptive immune receptors are critical for an optimal immune response, but the role played by Ag receptors in modulating innate receptor functions is less clear. TLRs are a family of pattern recognition receptors that play crucial roles in detecting microbial pathogens and subsequent development of immune responses. However, chronic stimulation through TLRs renders immune cells hyporesponsive to subsequent stimulation with TLR ligands, a phenomenon known as TLR tolerance, well characterized in myeloid cells. However, it has not been studied in detail in B lymphocytes. In addition to the BCR, B cells express almost all known TLRs and respond robustly to many TLR ligands. Thus, B cells may receive signals through both TLRs and BCR during an infection and may respond differently to TLR stimulation than myeloid cells. We tested this possibility by stimulating repeatedly through either TLR alone or both TLR and BCR. Prestimulation through TLR7 resulted in reduced B cell proliferation, cytokine production, and IgM secretion upon subsequent TLR7 restimulation. The hyporesponsiveness to TLR7 restimulation was associated with reduced NF-kappaB and MAPK activation and defective c-Jun phosphorylation. However, simultaneous BCR signaling prevented or reversed TLR7 tolerance in both mouse and human B cells. Importantly, BCR signaling also rescued B cells from TLR7-mediated TLR9 tolerance. Additionally, the reversal of TLR7-mediated JNK activation was dependent on PI3K activation. Together these results present a novel mechanism to prevent and reverse TLR tolerance in B cells.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19648281      PMCID: PMC2789010          DOI: 10.4049/jimmunol.0900495

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  59 in total

1.  IL-12 suppression during experimental endotoxin tolerance: dendritic cell loss and macrophage hyporesponsiveness.

Authors:  M Wysocka; S Robertson; H Riemann; J Caamano; C Hunter; A Mackiewicz; L J Montaner; G Trinchieri; C L Karp
Journal:  J Immunol       Date:  2001-06-15       Impact factor: 5.422

Review 2.  Toll receptors, CD14, and macrophage activation and deactivation by LPS.

Authors:  Marina A Dobrovolskaia; Stefanie N Vogel
Journal:  Microbes Infect       Date:  2002-07       Impact factor: 2.700

3.  Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression.

Authors:  A E Medvedev; K M Kopydlowski; S N Vogel
Journal:  J Immunol       Date:  2000-06-01       Impact factor: 5.422

4.  Natural and synthetic TLR7 ligands inhibit CpG-A- and CpG-C-oligodeoxynucleotide-induced IFN-alpha production.

Authors:  Beate Berghöfer; Gabriela Haley; Ture Frommer; Gregor Bein; Holger Hackstein
Journal:  J Immunol       Date:  2007-04-01       Impact factor: 5.422

5.  Gamma interferon and granulocyte/monocyte colony-stimulating factor prevent endotoxin tolerance in human monocytes by promoting interleukin-1 receptor-associated kinase expression and its association to MyD88 and not by modulating TLR4 expression.

Authors:  Minou Adib-Conquy; Jean-Marc Cavaillon
Journal:  J Biol Chem       Date:  2002-05-24       Impact factor: 5.157

Review 6.  Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.

Authors:  A J Marshall; H Niiro; T J Yun; E A Clark
Journal:  Immunol Rev       Date:  2000-08       Impact factor: 12.988

7.  The immune response modifiers imiquimod and R-848 are potent activators of B lymphocytes.

Authors:  M A Tomai; L M Imbertson; T L Stanczak; L T Tygrett; T J Waldschmidt
Journal:  Cell Immunol       Date:  2000-07-10       Impact factor: 4.868

8.  Phosphatidylinositol 3-kinase is involved in Toll-like receptor 4-mediated cytokine expression in mouse macrophages.

Authors:  Marja Ojaniemi; Virpi Glumoff; Kirsi Harju; Mari Liljeroos; Kristiina Vuori; Mikko Hallman
Journal:  Eur J Immunol       Date:  2003-03       Impact factor: 5.532

9.  A variety of microbial components induce tolerance to lipopolysaccharide by differentially affecting MyD88-dependent and -independent pathways.

Authors:  Shintaro Sato; Osamu Takeuchi; Takashi Fujita; Hideyuki Tomizawa; Kiyoshi Takeda; Shizuo Akira
Journal:  Int Immunol       Date:  2002-07       Impact factor: 4.823

10.  Convergence of CpG DNA- and BCR-mediated signals at the c-Jun N-terminal kinase and NF-kappaB activation pathways: regulation by mitogen-activated protein kinases.

Authors:  Ae-Kyung Yi; Jae-Geun Yoon; Arthur M Krieg
Journal:  Int Immunol       Date:  2003-05       Impact factor: 4.823

View more
  18 in total

Review 1.  Roles of the NF-kappaB pathway in lymphocyte development and function.

Authors:  Steve Gerondakis; Ulrich Siebenlist
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-23       Impact factor: 10.005

2.  Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patients.

Authors:  Eleni Arvaniti; Stavroula Ntoufa; Nikos Papakonstantinou; Tasoula Touloumenidou; Nikolaos Laoutaris; Achilles Anagnostopoulos; Klea Lamnissou; Federico Caligaris-Cappio; Kostas Stamatopoulos; Paolo Ghia; Marta Muzio; Chrysoula Belessi
Journal:  Haematologica       Date:  2011-07-12       Impact factor: 9.941

Review 3.  Roles of tumor necrosis factor receptor associated factor 3 (TRAF3) and TRAF5 in immune cell functions.

Authors:  Joanne M Hildebrand; Zuoan Yi; Claire M Buchta; Jayakumar Poovassery; Laura L Stunz; Gail A Bishop
Journal:  Immunol Rev       Date:  2011-11       Impact factor: 12.988

Review 4.  Toll-like receptors and B cells: functions and mechanisms.

Authors:  Claire M Buchta; Gail A Bishop
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

5.  Distinct innate immunity pathways to activation and tolerance in subgroups of chronic lymphocytic leukemia with distinct immunoglobulin receptors.

Authors:  Stavroula Ntoufa; Anna Vardi; Nikos Papakonstantinou; Achilles Anagnostopoulos; Vassiliki Aleporou-Marinou; Chrysoula Belessi; Paolo Ghia; Federico Caligaris-Cappio; Marta Muzio; Kostas Stamatopoulos
Journal:  Mol Med       Date:  2012-12-06       Impact factor: 6.354

6.  TLR-mediated activation of Waldenström macroglobulinemia B cells reveals an uncoupling from plasma cell differentiation.

Authors:  Jennifer Shrimpton; Matthew A Care; Jonathan Carmichael; Kieran Walker; Paul Evans; Charlotte Evans; Ruth de Tute; Roger Owen; Reuben M Tooze; Gina M Doody
Journal:  Blood Adv       Date:  2020-06-23

7.  Adoptive transfer of tumor reactive B cells confers host T-cell immunity and tumor regression.

Authors:  Qiao Li; Xiangming Lao; Qin Pan; Ning Ning; Ji Yet; Yingxin Xu; Shengping Li; Alfred E Chang
Journal:  Clin Cancer Res       Date:  2011-06-20       Impact factor: 12.531

8.  A role for TLR signaling during B cell activation in antiretroviral-treated HIV individuals.

Authors:  Basile Siewe; Ali Keshavarzian; Audrey French; Patricia Demarais; Alan Landay
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-16       Impact factor: 2.205

9.  Hyper-responsive Toll-like receptor 7 and 9 activation in NADPH oxidase-deficient B lymphoblasts.

Authors:  Shawna McLetchie; Bryan D Volpp; Mary C Dinauer; Janice S Blum
Journal:  Immunology       Date:  2015-09-29       Impact factor: 7.397

Review 10.  Differential impact of Toll-like receptor signaling on distinct B cell subpopulations.

Authors:  Almut Meyer-Bahlburg; David J Rawlings
Journal:  Front Biosci (Landmark Ed)       Date:  2012-01-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.